Overview

Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic Keratosis

Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
To identify the Maximum Tolerated Dose levels of ingenol mebutate gel after once daily treatment for 2 or 3 consecutive days and to evaluate efficacy of ingenol mebutate gel in different doses after once daily treatment for 2 or 3 consecutive days compared to vehicle gel
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
LEO Pharma